Does SELPERCATINIB Cause Disease progression? 5 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 5 reports of Disease progression have been filed in association with SELPERCATINIB (RETEVMO). This represents 0.5% of all adverse event reports for SELPERCATINIB.
5
Reports of Disease progression with SELPERCATINIB
0.5%
of all SELPERCATINIB reports
3
Deaths
0
Hospitalizations
How Dangerous Is Disease progression From SELPERCATINIB?
Of the 5 reports, 3 (60.0%) resulted in death.
Is Disease progression Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for SELPERCATINIB. However, 5 reports have been filed with the FAERS database.
What Other Side Effects Does SELPERCATINIB Cause?
Malignant neoplasm progression (106)
Death (90)
Hypertension (58)
Hypersensitivity (55)
Diarrhoea (54)
Fatigue (51)
Rash (49)
Hepatic function abnormal (42)
Alanine aminotransferase increased (38)
Pyrexia (38)
What Other Drugs Cause Disease progression?
RITUXIMAB (7,282)
CYCLOPHOSPHAMIDE (7,100)
DOXORUBICIN (6,165)
VINCRISTINE (5,252)
PREDNISONE (5,096)
BEVACIZUMAB (4,653)
DEXAMETHASONE (4,545)
CARBOPLATIN (4,538)
CAPECITABINE (3,808)
ETOPOSIDE (3,776)
Which SELPERCATINIB Alternatives Have Lower Disease progression Risk?
SELPERCATINIB vs SELUMETINIB
SELPERCATINIB vs SEMAGLUTIDE
SELPERCATINIB vs SEMUSTINE
SELPERCATINIB vs SENNA LEAF
SELPERCATINIB vs SENNA LEAF\SENNOSIDES\SENNOSIDES A AND B